Investor Syncona Portfolio Ltd
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Syncona Portfolio Ltd . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Date Form Target Prev
Shares
Current
Shares
Change
(Percent)
Ownership
(Percent)
Change
(Percent)
2025-05-07 13G/A AUTL / Autolus Therapeutics plc - Depositary Receipt (Common Stock) 30,734,957 28,821,053
2024-11-14 13G/A AUTL / Autolus Therapeutics plc - Depositary Receipt (Common Stock) 33,527,162 30,734,957
2024-02-22 13D/A US35655L1070 / Freeline Therapeutics Holdings PLC 65,872,764
2024-02-13 13G/A AUTL / Autolus Therapeutics plc - Depositary Receipt (Common Stock) 33,527,162 33,527,162
2024-02-13 13G/A ACHL / Achilles Therapeutics plc - Depositary Receipt (Common Stock) 11,086,909 11,086,909
2023-11-24 13D/A FRLN / Freeline Therapeutics Holdings plc - Depositary Receipt (Common Stock) 37,862,132 37,862,132
2023-10-18 13D/A FRLN / Freeline Therapeutics Holdings plc - Depositary Receipt (Common Stock) 37,862,132
2023-02-14 13G/A AUTL / Autolus Therapeutics plc - Depositary Receipt (Common Stock) 19,527,162 33,527,162
2022-03-25 13D 18,814,527 37,862,147
2022-02-11 13G ACHL / Achilles Therapeutics plc - Depositary Receipt (Common Stock) 11,086,909
2022-02-11 13G/A 18,814,527 18,814,527
2022-02-11 13G/A AUTL / Autolus Therapeutics plc - Depositary Receipt (Common Stock) 15,955,734 19,527,162
2021-02-12 13G 18,814,527
2021-02-12 13G/A AUTL / Autolus Therapeutics plc - Depositary Receipt (Common Stock) 14,592,098 15,955,734
2020-02-11 13G/A AUTL / Autolus Therapeutics plc - Depositary Receipt (Common Stock) 13,592,098 14,592,098
2019-03-14 13G/A NITE / Capitol Series Trust - The Nightview Fund 13,203,922 13,203,922
2019-02-14 13G/A AUTL / Autolus Therapeutics plc - Depositary Receipt (Common Stock) 13,592,098 13,592,098
2019-02-13 13G AUTL / Autolus Therapeutics plc - Depositary Receipt (Common Stock) 13,592,098
2019-02-13 13G/A NITE / Capitol Series Trust - The Nightview Fund 12,203,922 13,203,922
2018-02-02 13G NITE / Capitol Series Trust - The Nightview Fund 12,203,922